z-logo
Premium
Etiology of non‐immune hydrops fetalis: An update
Author(s) -
Bellini Carlo,
Donarini Gloria,
Paladini Dario,
Calevo Maria Grazia,
Bellini Tommaso,
Ramenghi Luca A,
Hennekam Raoul C
Publication year - 2015
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.36988
Subject(s) - hydrops fetalis , etiology , medicine , multiple myeloma , dysplasia , pregnancy , fetus , pathology , immunology , biology , genetics
Hydrops fetalis is an excessive fluid accumulation within the fetal extra vascular compartments and body cavities. Non‐immune hydrops fetalis (NIHF), due to causes other than Rh alloimmunization, is the cause in >85% of all affected individuals. Herein we present an update of our earlier systematic literature review [Bellini et al., 2009] using all publications between 2007 and 2013. We excluded most of the initial 31,783 papers by using strict selection criteria, thus resulting in 24 relevant NIHF publications describing 1,338 individuals with NIHF. We subdivided the affected individuals into 14 classification groups based on the cause of NIHF (percentage of the total group): Cardiovascular (20.1%), Hematologic (9.3%), Chromosomal (9.0%), Syndromic (5.5%), Lymphatic Dysplasia (15.0%), Inborn Errors of Metabolism (1.3%), Infections (7.0%), Thoracic (2.3%), Urinary Tract Malformations (0.9%), Extra Thoracic Tumors (0.7%), TTTF‐Placental (4.1%), Gastrointestinal (1.3%), Miscellaneous (3.6%), Idiopathic (19.8%). We discuss the results of the review. There may be some shifts in the percentages of etiological categories as compared to the previous review, but the small numbers within each category make drawing firm conclusions hazardous. We highlight the need for multi‐center series of NIHF cases collected and classified using the same schemes in diagnostic work‐ups to allow for comparisons of larger numbers of cases. © 2015 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here